Thomas Cuisset

Summary

Country: France

Publications

  1. ncbi request reprint Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    J Am Coll Cardiol 48:1339-45. 2006
  2. ncbi request reprint High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
    T Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    J Thromb Haemost 4:542-9. 2006
  3. ncbi request reprint High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Boulevard Saint Pierre, Marseille, Bouches du rhone, 13005 France
    Thromb Haemost 97:282-7. 2007
  4. ncbi request reprint Coronary-subclavian steal syndrome: an usual cause of refractory unstable angina
    Thomas Cuisset
    Int J Cardiol 127:e181-2. 2008
  5. doi request reprint Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Am J Cardiol 104:1078-82. 2009
  6. doi request reprint Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, France
    Am Heart J 164:327-33. 2012
  7. pmc Giant coronary artery aneurysm in Behcet's disease
    T Cuisset
    Heart 93:1375. 2007
  8. doi request reprint Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, 13385 France
    Thromb Res 123:597-603. 2009
  9. ncbi request reprint Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris
    Thomas Cuisset
    Cardiovascular Center, OLV Hospital, Aalst, Belgium
    Am J Cardiol 101:1700-3. 2008
  10. doi request reprint Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical management
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Arch Cardiovasc Dis 104:306-12. 2011

Detail Information

Publications55

  1. ncbi request reprint Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    J Am Coll Cardiol 48:1339-45. 2006
    ..We analyzed the benefit of a 600-mg clopidogrel loading dose on platelet reactivity and clinical outcomes after stenting for non-ST-segment elevation acute coronary syndrome (NSTE ACS)...
  2. ncbi request reprint High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome
    T Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    J Thromb Haemost 4:542-9. 2006
    ..Low response to antiplatelet therapy may be a risk factor for the development of ischemic complications in patients with non-ST segment elevation acute coronary syndrome (NSTE ACS) undergoing coronary stenting...
  3. ncbi request reprint High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Boulevard Saint Pierre, Marseille, Bouches du rhone, 13005 France
    Thromb Haemost 97:282-7. 2007
    ..24%, p=0.014). After being correlated with recurrent ischemic events after stenting for NSTE-ACS, the HPPR seems to be also a marker of increased risk of periprocedural MI for NSTE-ACS patients...
  4. ncbi request reprint Coronary-subclavian steal syndrome: an usual cause of refractory unstable angina
    Thomas Cuisset
    Int J Cardiol 127:e181-2. 2008
    ..The angiography revealed a significant stenosis of the ostium of the left subclavian artery. The patient underwent successful stenting of the subclavian artery and remained symptom free until hospital discharge a few days later...
  5. doi request reprint Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Am J Cardiol 104:1078-82. 2009
    ....
  6. doi request reprint Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, France
    Am Heart J 164:327-33. 2012
    ..Studies have addressed the benefit of tailored therapy based on initial response to clopidogrel loading dose. However, the appropriate timing for platelet testing remains uncertain...
  7. pmc Giant coronary artery aneurysm in Behcet's disease
    T Cuisset
    Heart 93:1375. 2007
  8. doi request reprint Relationship between aspirin and clopidogrel responses in acute coronary syndrome and clinical predictors of non response
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, 13385 France
    Thromb Res 123:597-603. 2009
    ..We have prospectively investigated the association between aspirin and clopidogrel responses and the clinical predictors of non response...
  9. ncbi request reprint Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris
    Thomas Cuisset
    Cardiovascular Center, OLV Hospital, Aalst, Belgium
    Am J Cardiol 101:1700-3. 2008
    ..6, 95% confidence interval 1.9 to 11.5, p=0.001). In conclusion, point-of-care assessment of clopidogrel response reliably predicted PMI after low- to medium-risk elective PCI for stable angina...
  10. doi request reprint Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical management
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Arch Cardiovasc Dis 104:306-12. 2011
    ..Premature discontinuation of and reduced adherence to antiplatelet therapy have been identified as major risk factors for stent thrombosis and poor prognosis after acute coronary syndrome...
  11. doi request reprint Effect of increased aspirin dose after stenting in association with ClOpidogrel: the FIASCO randomized study
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, 13385 France
    Thromb Res 124:33-6. 2009
    ..Increased doses of antiplatelet therapy have been proposed to overcome the variability of response. However, the chronic dose of aspirin after DES remains controversial...
  12. ncbi request reprint Aspirin and clopidogrel resistance: should we worry about?
    T Cuisset
    Department of Cardiology, University Hospital of Marseille, Marseille, France
    Minerva Med 101:35-47. 2010
    ..The present review aims to summarize biological and clinical data about resistance to antiplatelet therapy, and try to estimate how much this might change our prescription in daily clinical practice...
  13. doi request reprint Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Am Heart J 157:889-93. 2009
    ..We investigated the hypothesis that biological aspirin "resistance" may often be related to noncompliance in patients undergoing coronary stenting...
  14. doi request reprint Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    JACC Cardiovasc Interv 1:649-53. 2008
    ....
  15. doi request reprint Clopidogrel response: head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Arch Cardiovasc Dis 103:39-45. 2010
    ..We investigated the agreement between different platelet tests to identify clopidogrel non response...
  16. ncbi request reprint Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    EuroIntervention 5:325-9. 2009
    ..We assessed prospectively the association between occurrence of post-discharge non-CABG-related TIMI major and minor bleeding and post-treatment platelet reactivity in patients with non-ST elevation acute coronary syndrome (NSTE ACS)...
  17. doi request reprint Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, France
    Am J Cardiol 108:760-5. 2011
    ..The benefit of this tailored therapy was significantly reduced in CYP2C19*2 carriers. Therefore, these patients might require alternative strategies with new P2Y₁₂ blockers...
  18. doi request reprint Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, France
    Am J Cardiol 108:1411-6. 2011
    ..They display greater post-treatment platelet reactivity. However, this greater platelet reactivity does not seem to be related to an impaired specific response to clopidogrel...
  19. ncbi request reprint [Beneficial effect of a loading dose of 600 mg of clopidogrel on platelet parameters in patients admitted for acute coronary syndrome]
    T Cuisset
    Département de cardiologie interventionnelle CHU de la Timone
    Arch Mal Coeur Vaiss 99:889-93. 2006
    ..Despite the beneficial effect of an aspirin-clopidogrel combination in acute coronary syndrome, the incidence of ischaemic recurrences remains significant and very probably implicates a variability in the response to anti-platelet agents...
  20. ncbi request reprint [Acute stent thrombosis due to resistance to clopidogrel ? A case report]
    T Cuisset
    Departement de Cardiologie, CHU de la Timone, UMR INSERM, 626, bd Saint Pierre, 13005 Marseille
    Arch Mal Coeur Vaiss 100:145-8. 2007
    ..This clinical case illustrates the possible role of "resistance" to antiplatelet drugs in stent thromboses...
  21. doi request reprint Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs)
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, France
    JACC Cardiovasc Interv 6:854-63. 2013
    ..We also aimed to identify predictors of bleeding and VLTPR in patients treated with thienopyridines...
  22. ncbi request reprint Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Thromb Haemost 97:212-7. 2007
    ..104). In conclusion, our study did not show any influence of 807 C/T polymorphism of GpIa gene on post-treatment platelet reactivity assessed by ADP-Ag, PRI VASP or P-selectin expression in 601 NSTE ACS patients...
  23. doi request reprint Effect of CYP2C19*2 and *17 genetic variants on platelet response to clopidogrel and prasugrel maintenance dose and relation to bleeding complications
    Charlotte Grosdidier
    INSERM, UMR1062, Nutrition, Obesity and Risk of Thrombosis, Marseille, France
    Am J Cardiol 111:985-90. 2013
    ..In addition, LTPR was associated with a greater risk of bleeding...
  24. doi request reprint Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndrome
    Corinne Frere
    INSERM U626, Marseille, France
    Am J Cardiol 101:1088-93. 2008
    ..03). In conclusion, the present data suggest that the CYPC19*2 allele influences post-treatment platelet reactivity and clopidogrel response in patients with non-ST elevation acute coronary syndromes...
  25. ncbi request reprint Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Thromb Res 120:893-9. 2007
    ..Recently, the T744C polymorphism of the P2Y12 receptor gene has been associated with enhanced platelet aggregation in healthy volunteers, suggesting a possible mechanism for modulation of clopidogrel response...
  26. doi request reprint Adrenergic receptor polymorphisms and platelet reactivity after treatment with dual antiplatelet therapy with aspirin and clopidogrel in acute coronary syndrome
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, France
    Thromb Haemost 103:774-9. 2010
    ..Common alpha2A- and beta2-adrenergic receptor polymorphisms do not show any major impact on residual platelet reactivity in non-ST-elevation ACS when a dual antiplatelet therapy with 250 mg aspirin and 600 mg clopidogrel is administered...
  27. ncbi request reprint ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome
    Corinne Frere
    INSERM, UMR 626, Faculté de Médecine CHU Timone, Marseille, France
    Thromb Haemost 98:838-43. 2007
    ..In patients with NSTE ACS undergoing PCI, ADP-Ag and PRI VASP identify low responders to clopidogrel with an increased risk of recurrent ischemic events with respective cut-off values of 70% and 53%...
  28. ncbi request reprint Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, F 13385 France
    Int J Cardiol 168:523-8. 2013
    ..The present study was designed to assess response to thienopyridine in diabetic patients undergoing PCI for ACS...
  29. doi request reprint CYP2C19*2 and *17 alleles have a significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndrome
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, France
    JACC Cardiovasc Interv 5:1280-7. 2012
    ..The present study was designed to assess the effect of genetic variants on chronic biological response to prasugrel and bleeding complications...
  30. doi request reprint Quantitative assessment of coronary microvascular function in patients with and without epicardial atherosclerosis
    Narbeh Melikian
    Cardiovascular Center, OLV Hospital, Aalst, Belgium
    EuroIntervention 5:939-45. 2010
    ..We examined the influence of epicardial vessel atherosclerosis on coronary microvascular function using the index of myocardial resistance (IMR)...
  31. doi request reprint Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille, France
    J Am Coll Cardiol 54:1149-53. 2009
    ..This study sought to compare the effect of 2 proton pump inhibitors (PPIs) on platelet response to clopidogrel after coronary stenting for non-ST-segment elevation acute coronary syndrome (NSTE ACS)...
  32. doi request reprint Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting
    Mathieu Pankert
    Departement de Cardiologie, Centre Hospitalo Universitaire Timone, Marseille, France Aix Marseille Univ, Institut National de la Sante et de la Recherche Medicale, Unité Mixte de Recherche 1062, Institut National de la Recherche Agronomique, Unité Mixte de Recherche 1260, Nutrition, Obesity and Risk of Thrombosis, Faculty of Medicine, Marseille, France
    Am J Cardiol 113:54-9. 2014
    ..However, among obese patients, the presence of the MS strongly affects response to antiplatelet agents, indicating that the metabolic status might be a better predictor of platelet inhibition than BMI...
  33. doi request reprint Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses
    Michalis Hamilos
    Cardiovascular Centre Aalst, OLV Hospital, Moorselbaan 164, Aalst, Belgium
    Circ Cardiovasc Interv 1:193-200. 2008
    ..We studied the effects of different drug-polymer-device iterations on endothelium-dependent coronary vasomotion. Systemic markers of endothelial inflammation were correlated with coronary vasomotor changes...
  34. doi request reprint In vitro and in vivo studies on thermistor-based intracoronary temperature measurements: effect of pressure and flow
    Thomas Cuisset
    Cardiovascular Center, OLV Hospital, Aalst, Belgium
    Catheter Cardiovasc Interv 73:224-30. 2009
    ..Intracoronary thermography has been proposed to detect vulnerable plaques. We hypothesized that changes in coronary pressure and flow in the coronary tree may interfere with the temperature measurements obtained with thermistors...
  35. doi request reprint Direct stenting for stable angina pectoris is associated with reduced periprocedural microcirculatory injury compared with stenting after pre-dilation
    Thomas Cuisset
    Cardiovascular Center, OLV Hospital, Aalst, Belgium
    J Am Coll Cardiol 51:1060-5. 2008
    ..We conducted a randomized study to compare the effect of direct stenting (DS) and conventional stenting (CS) on post-procedural index of microcirculatory resistance (IMR) values...
  36. doi request reprint Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate
    Laurent Bonello
    Department of Cardiology, Institut National de la Santè et de la Recherche Médicale Unité Mixte de Recherche 608, Hopital Universitaire Nord, Faculte de Medecine, Marseille, France
    J Am Coll Cardiol 56:919-33. 2010
    ..This review provides a consensus opinion on the definition of high on-treatment platelet reactivity to ADP based on various methods reported in the literature and proposes how this measurement may be used in the future care of patients...
  37. doi request reprint Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel
    Michalis Hamilos
    Cardiovascular Center Aalst, OLV Hospital, Moorselbaan 164, 9300, Aalst, Belgium
    J Thromb Thrombolysis 32:64-71. 2011
    ..This improvement is associated with optimal platelet inhibition and it is not observed in patients with post-clopidogrel high platelet reactivity...
  38. doi request reprint Epicardial fat volume is associated with coronary microvascular response in healthy subjects: a pilot study
    Benedicte Gaborit
    Centre de Résonance Magnétique Biologique et Médicale CRMBM, CNRS UMR 6612, Marseille, France
    Obesity (Silver Spring) 20:1200-5. 2012
    ..A high EF amount is associated with a lower coronary microvascular response, suggesting that EF could early influence endothelial function...
  39. ncbi request reprint Coronary wall characteristics after myocardial infarction without significant coronary angiographic lesion: an intravascular ultrasound study
    Raphael Poyet
    Department of Cardiology, CHU Timone, Marseille, France
    Acta Cardiol 65:627-30. 2010
    ..Our aim was to evaluate intravascular ultrasound (IVUS) findings, mainly remodelling, in patients with normal or near normal angiography early after MI...
  40. doi request reprint Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis
    Michalis Hamilos
    Cardiovascular Center Aalst, OLV Hospital, Moorselbaan, 164, B 9300 Aalst, Belgium
    Circulation 120:1505-12. 2009
    ....
  41. ncbi request reprint Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes
    Laurent Bali
    Department of Cardiology, CHU La Timone, 264, rue Saint Pierre, 13005 Marseille, France
    Arch Cardiovasc Dis 101:645-51. 2008
    ..The purpose of the study was to analyse the prognostic value of IMA in patients admitted for non-ST-segment elevation acute coronary syndromes (NSTE ACS)...
  42. doi request reprint Recent advances in the pharmacogenetics of clopidogrel
    Thomas Cuisset
    Department of Cardiology, CHU Timone, Marseille, France
    Hum Genet 131:653-64. 2012
    ..The purpose of this review is to discuss the contribution of individual genetic differences responsible for variations of action and clopidogrel efficacy...
  43. doi request reprint On the inappropriateness of noninvasive multidetector computed tomography coronary angiography to trigger coronary revascularization: a comparison with invasive angiography
    Giovanna Sarno
    Cardiovascular Center, OLV Hospital, Aalst, Belgium
    JACC Cardiovasc Interv 2:550-7. 2009
    ..Our purpose was to evaluate the appropriateness of multidetector computed tomography angiography (MDCTA) as an anatomical standard for decision making in patients with known or suspected coronary artery disease...
  44. doi request reprint CYP-mediated pharmacologic interference with optimal platelet inhibition
    Thomas Cuisset
    Departement de Cardiologie, CHU Timone, Marseille F 13385, France
    J Cardiovasc Transl Res 6:404-10. 2013
    ..The present review aims to summarize available scientific evidence about CYP-mediated pharmacologic interference with optimal platelet inhibition in patients treated with thienopyridine...
  45. doi request reprint Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content
    Benedicte Gaborit
    Department of Endocrinology, Metabolic Diseases and Nutrition, Centre Hospitalier Universitaire Nord, Marseille, France
    J Am Coll Cardiol 60:1381-9. 2012
    ..This study investigated the effect of bariatric surgery (BS)-induced weight loss on cardiac ectopic fat using 3T magnetic resonance imaging in morbid obesity...
  46. doi request reprint Role of antiplatelet therapy in secondary prevention of acute coronary syndrome
    Mathieu Pankert
    Departement de Cardiologie, CHU Timone, Marseille, 13385, France
    J Cardiovasc Transl Res 5:41-51. 2012
    ..The present review aims to provide a current appraisal of antiplatelet therapy use after ACS and to summarize available scientific evidence for an optimal use of antiplatelet agents in daily practice, including the new P2Y12 blockers...
  47. doi request reprint Fractional flow reserve: concepts, applications and use in France in 2010
    Etienne Puymirat
    Cardiovascular Center Aalst, OLV Clinic, Moorselbaan 164, 9300, Aalst, Belgium
    Arch Cardiovasc Dis 103:615-22. 2010
    ..The use of FFR is still limited in France because there is no financial support. The present review will focus on coronary pressure-derived FFR...
  48. doi request reprint Transradial approach and subclavian wired temporary pacemaker to increase safety of alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: the TRASA trial
    Thomas Cuisset
    Departement de Cardiologie, CHU de la Timone, Marseille, France
    Arch Cardiovasc Dis 104:444-9. 2011
    ..In addition, femoral artery catheterization has resulted in a concomitant increase in bleedings and iatrogenic femoral artery injuries...
  49. doi request reprint Mononuclear cell adenosine deaminase and CD26/dipeptidylpeptidase-IV activities are sensitive markers of reperfusion during percutaneous transluminal angioplasty
    Pierre Julien Moro
    Department of Cardiology, Timone University Hospital, Marseille, France
    Int J Cardiol 166:225-9. 2013
    ..Enzymatic activities were compared with levels of ischaemia-modified albumin (IMA), a marker of ischaemia-reperfusion...
  50. ncbi request reprint [Endomyocardial fibrosis: a rare case of restrictive cardiomyopathy in a Caucasian female]
    T Cuisset
    Service de cardiologie interventionnelle, CHU de la Timone, bd Saint Pierre, Marseille
    Arch Mal Coeur Vaiss 99:73-6. 2006
    ..The patient was discharged on the eighth postoperative day, much improved clinically, and follow-up at one year was very satisfactory...
  51. doi request reprint Three-dimensional transesophageal echocardiography assessment of a successful transcatheter mitral valve in valve implantation for degenerated bioprosthesis
    Alexis Théron
    Department of Cardiac Surgery, La Timone Hospital, Marseille, France
    Echocardiography 30:E152-5. 2013
    ..Live three-dimensional TEE was used during the implantation for sizing, device positioning, and hemodynamic assessment. ..
  52. ncbi request reprint Adjusting clopidogrel loading doses according to vasodilator-stimulated phosphoprotein index: on time, too early, or too late?
    Thomas Cuisset
    J Am Coll Cardiol 52:790-1; author reply 791-2. 2008
  53. ncbi request reprint Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention
    Marzia Lotrionte
    Institute of Cardiology, Catholic University, Rome, Italy
    Am J Cardiol 100:1199-206. 2007
    ..In conclusion, a high clopidogrel loading dose (>300 mg) significantly reduces early ischemic events in patients scheduled for percutaneous coronary intervention...
  54. ncbi request reprint Diagnosis contribution of IVUS in embolic myocardial infarction
    Thomas Cuisset
    Int J Cardiol 124:e47-8. 2008
  55. ncbi request reprint Coronary aneurysm in Lyme Disease: treatment by covered stent
    Thomas Cuisset
    Int J Cardiol 128:e72-3. 2008